Dialysis Modalities: What the Non-Nephrologist Needs to Know

نویسنده

  • Brian S. Rifkin
چکیده

Hospital Physician August 2006 11 D ialysis has been used as a life-saving technique for decades but has been universally available as a chronic therapy for only approximately 30 years. In the United States, there are currently more than 300,000 patients undergoing dialysis, and the prevalence of end-stage renal disease (ESRD) is growing yearly.1 Diabetes and hypertension, which are growing to epidemic status in some areas of the United States, account for more than 50% of new ESRD patients. For eligible patients, kidney transplantation is the best treatment for ESRD.2 Rarely, some patients are able to obtain a preemptive transplant and never need to start dialysis. However, most patients who start dialysis will need it for the rest of their lives or until they undergo kidney transplantation. For others, dialysis is needed acutely while waiting for renal function to recover from a specific injury. Physicians in all specialties should have a working knowledge of dialysis. Primary care physicians play a critical role in identifying patients at risk for ESRD. In addition, as more patients live longer on dialysis, physicians in all specialties need to be familiar with the basic elements of dialysis to assist in their care. Surgeons who are to operate on ESRD patients need to be familiar with dialysis to understand the importance of scheduling surgery around dialysis as well as the volume and electrolyte control options available postoperatively. This article will review dialysis modalities for patients on chronic therapy and briefly address modalities used in the acute setting. The modalities that are currently available to patients with ESRD are hemodialysis and peritoneal dialysis. A basic knowledge of the workings of each type of dialysis will help physicians guide patients to the most appropriate form of renal replacement therapy. A brief glossary of common dialysis terms is provided in Table 1.

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Biosimilars and biopharmaceuticals: what the nephrologist needs to know--a position paper by the ERA-EDTA Council.

25 Le Michelangelo, 7 Avenue des Papalins, Monaco 98000, Monaco Nephrol Dial Transplant 2009; doi:10.1093/ndt/gfp119 By mistake, the date of publication on Advanced Access (March 27, 2009) was not printed above Dr Shaldon’s letter. Dr Shaldon’s revised letter was accepted on February 4, 2009. Dr Macdougall’s letter and the corresponding reply from Dr Covic, which directly precede Dr Shaldon’s l...

متن کامل

Renal transplantation outcome in children with cystinosis

Background and Objective: Cystinosis is a rare inherited disease that leads to renal failure. Fanconi syndrome is the major renal involvement in cystinosis patients. Renal transplantation is the treatment of choice in cystinosis children with end-stage renal disease (ESRD).  The study aimed to assess the outcome of renal transplantation in Iranian children with cystinosis. Methods: This...

متن کامل

Superior Capsule Reconstruction: What Do We Know?

The management of irreparable rotator cuff tears remains challenging. Since its introduction by Mihata in 2012, superiorcapsule reconstruction (SCR) has grown in popularity at an astonishingly rapid rate. The aim of this article is to providea comprehensive review of the available literature, in order to highlight what has so far been published on SCR,covering all aspects including biomechanica...

متن کامل

Beta trace protein as GFR marker in children

Background and Objective: Serum creatinine is the most used endogenous marker of glomerular filtration rate (GFR), but it also has multiple limitations. Therefore, some surrogate GFR markers, such as beta trace protein, have been introduced for GFR estimation. The aim of our study was to estimate GFR by serum beta trace protein using three available equations and compare them to DTPA GFR as the...

متن کامل

Medicare from A to D: what every nephrologist needs to know.

I n 1972, the Congress of the United States put insurance coverage for ESRD under Medicare. Thus, most patients who required dialysis and transplantation in the United States were covered by this program, enabling widespread application of these treatments for kidney failure. The system of coverage is complex, and often patients and their physicians are confused about the regulations and intric...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2006